RecruitingNot ApplicableNCT06651944

Invisalign® System with Mandibular Advancement

Invisalign® System with Mandibular Advancement Featuring Occlusal Blocks (MAOB) Post-Market Study

Sponsor

Align Technology, Inc.

Enrollment

36 participants

Start Date

Feb 14, 2024

Study Type

INTERVENTIONAL

Conditions

Class II Malocclusion Mandibular Advancement Mandibular Retrognathism Excessive Overjet

Summary

The goal of this clinical trial is to observe study participants' comfort and fit of their aligners with occlusal blocks, as well as evaluate the engagement of the blocks using the Invisalign® System with mandibular advancement featuring occlusal blocks

Eligibility

Min Age: 10 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Invisalign® System with mandibular advancement featuring occlusal blocks for people with class ii malocclusion, excessive overjet, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 10 Years to 16 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.